MARKET OF VIETNAM
Vietnam’s pharmaceutical markets accounted $ 5.9 Bn in 2018. and expected to reach $ 6.55 in 2019. t is second largest pharmaceutical market in SEA. Vietnam healthcare market had value of $ 17.4 Bn in 2018, that represented 7.5% of country’s GDP. Government is a major contributor towards spending 56% of overall healthcare expenditure. Vietnamese drug makers account for 50% of total medicines market while the country’s import 90% of the active pharmaceutical ingredient. 2020 Strategy, Government wants 80% of domestic demand met by local pharma manufacturers.
- FOOD SUPPLEMENTS
- MEDICAL DEVICES
Building a brand for the principals we deal with is at the core of our company vision, and we work towards that with in house marketing team of more than 25 people associated with SV healthcare across market of Vietnam. We also engage ourselves in the national level symposiums, KOl management and participation in to various international level activities which shows the commitment of our team to give justice to the product we work with.
The very first and important part of the medicine business is Regulatory, which is also a internal part of the system we follow for ethical channel business. We have in house team of regulatory as well as external consultants to guide us on the developments as well as lead the registration activities with DAV.